{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:33:41Z","timestamp":1707525221905},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,11]]},"DOI":"10.7759\/cureus.45055","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T19:34:01Z","timestamp":1694460841000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Chronic Laxative Use on Lipid Profile and HbA1c: A Hospital-Based Retrospective Study"],"prefix":"10.7759","author":[{"given":"Ghada","family":"Ajabnoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basmah","family":"Eldakhakhny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal T","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed M","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan","family":"Eskandarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader","family":"AlQusaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad K","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naser M","family":"Alsulaimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour","family":"Dahlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumia","family":"Enani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Almoghrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliaa A","family":"Alamoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Alhozali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Elsamanoudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008788726842","article-title":"Abuse\/misuse of non-prescription drugs","volume":"21","author":"Hughes GF","year":"1999","unstructured":"Hughes GF, McElnay JC, Hughes CM, McKenna P. Abuse\/misuse of non-prescription drugs. Pharm World Sci. 1999, 21:251-5. 10.1023\/a:1008788726842","journal-title":"Pharm World Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.37.51.24098","article-title":"Current self-medication practices in the Kingdom of Saudi Arabia: an observational study","volume":"37","author":"Al-Ghamdi S","year":"2020","unstructured":"Al-Ghamdi S, Alfauri TM, Alharbi MA, et al.. Current self-medication practices in the Kingdom of Saudi Arabia: an observational study. Pan Afr Med J. 2020, 37:51. 10.11604\/pamj.2020.37.51.24098","journal-title":"Pan Afr Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1301754","article-title":"Medical management of constipation","volume":"25","author":"Portalatin M","year":"2012","unstructured":"Portalatin M, Winstead N. Medical management of constipation. Clin Colon Rectal Surg. 2012, 25:12-9. 10.1055\/s-0032-1301754","journal-title":"Clin Colon Rectal Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/11898640-000000000-00000","article-title":"Laxative abuse: epidemiology, diagnosis and management","volume":"70","author":"Roerig JL","year":"2010","unstructured":"Roerig JL, Steffen KJ, Mitchell JE, Zunker C. Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010, 70:1487-503. 10.2165\/11898640-000000000-00000","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5414\/cpp46089","article-title":"OTC laxative use of sodium picosulfate \u00e2 results of a pharmacy-based patient survey (cohort study)","volume":"46","author":"Hinkel U","year":"2008","unstructured":"Hinkel U, Schuijt C, Erckenbrecht JF. OTC laxative use of sodium picosulfate \u00e2 results of a pharmacy-based patient survey (cohort study). Int J Clin Pharmacol Ther. 2008, 46:89-95. 10.5414\/cpp46089","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2375676","article-title":"Gut bacteria selectively altered by sennoside A alleviate type 2 diabetes and obesity traits","volume":"2020","author":"Wei Z","year":"2020","unstructured":"Wei Z, Shen P, Cheng P, Lu Y, Wang A, Sun Z. Gut bacteria selectively altered by sennoside A alleviate type 2 diabetes and obesity traits. Oxid Med Cell Longev. 2020, 2020:2375676. 10.1155\/2020\/2375676","journal-title":"Oxid Med Cell Longev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000139853","article-title":"Adverse effects of laxatives: fact and fiction","volume":"47 Suppl 1","author":"M\u00fcller-Lissner SA","year":"1993","unstructured":"M\u00fcller-Lissner SA. Adverse effects of laxatives: fact and fiction. Pharmacology. 1993, 47 Suppl 1:138-45. 10.1159\/000139853","journal-title":"Pharmacology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.780127","article-title":"Effects of elobixibat on constipation and lipid metabolism in patients with moderate to end-stage chronic kidney disease","volume":"8","author":"Matsuyama M","year":"2021","unstructured":"Matsuyama M, Hirai K, Nonaka H, et al.. Effects of elobixibat on constipation and lipid metabolism in patients with moderate to end-stage chronic kidney disease. Front Med (Lausanne). 2021, 8:780127. 10.3389\/fmed.2021.780127","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00375.2012","article-title":"Laxative treatment with polyethylene glycol decreases microbial primary bile salt dehydroxylation and lipid metabolism in the intestine of rats","volume":"305","author":"van der Wulp MY","year":"2013","unstructured":"van der Wulp MY, Derrien M, Stellaard F, et al.. Laxative treatment with polyethylene glycol decreases microbial primary bile salt dehydroxylation and lipid metabolism in the intestine of rats. Am J Physiol Gastrointest Liver Physiol. 2013, 305:G474-82. 10.1152\/ajpgi.00375.2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13698","article-title":"Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: a randomized controlled trial","volume":"84","author":"Kumagai Y","year":"2018","unstructured":"Kumagai Y, Amano H, Sasaki Y, Nakagawa C, Maeda M, Oikawa I, Furuie H. Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: a randomized controlled trial. Br J Clin Pharmacol. 2018, 84:2393-404. 10.1111\/bcp.13698","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02243-w","article-title":"Effects of elobixibat in patients with diabetes and concomitant chronic constipation: an 8-week, prospective, single-center, single-arm study","volume":"39","author":"Hishida Y","year":"2022","unstructured":"Hishida Y, Nagai Y, Tsukiyama H, et al.. Effects of elobixibat in patients with diabetes and concomitant chronic constipation: an 8-week, prospective, single-center, single-arm study. Adv Ther. 2022, 39:4205-17. 10.1007\/s12325-022-02243-w","journal-title":"Adv Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40519-017-0456-z","article-title":"Body weight and mortality in COPD: focus on the obesity paradox","volume":"23","author":"Spelta F","year":"2018","unstructured":"Spelta F, Fratta Pasini AM, Cazzoletti L, Ferrari M. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord. 2018, 23:15-22. 10.1007\/s40519-017-0456-z","journal-title":"Eat Weight Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12949","article-title":"The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality","volume":"286","author":"Park HJ","year":"2019","unstructured":"Park HJ, Cho JH, Kim HJ, Park JY, Lee HS, Byun MK. The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality. J Intern Med. 2019, 286:573-82. 10.1111\/joim.12949","journal-title":"J Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2022.100344","article-title":"Body mass index and survival after cancer diagnosis: a pan-cancer cohort study of 114 430 patients with cancer","volume":"3","author":"Tu H","year":"2022","unstructured":"Tu H, McQuade JL, Davies MA, et al.. Body mass index and survival after cancer diagnosis: a pan-cancer cohort study of 114 430 patients with cancer. Innovation (Camb). 2022, 3:100344. 10.1016\/j.xinn.2022.100344","journal-title":"Innovation (Camb)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/21623945.2018.1525252","article-title":"Subcutaneous adipose tissue accumulation protects systemic glucose tolerance and muscle metabolism","volume":"7","author":"Booth AD","year":"2018","unstructured":"Booth AD, Magnuson AM, Fouts J, Wei Y, Wang D, Pagliassotti MJ, Foster MT. Subcutaneous adipose tissue accumulation protects systemic glucose tolerance and muscle metabolism. Adipocyte. 2018, 7:261-72. 10.1080\/21623945.2018.1525252","journal-title":"Adipocyte"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: structural and functional differences","volume":"11","author":"Ibrahim MM","year":"2010","unstructured":"Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010, 11:11-8. 10.1111\/j.1467-789X.2009.00623.x","journal-title":"Obes Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(85)90091-9","article-title":"Estimation of VLDL cholesterol in hyperlipidemia","volume":"151","author":"Wilson PW","year":"1985","unstructured":"Wilson PW, Zech LA, Gregg RE, et al.. Estimation of VLDL cholesterol in hyperlipidemia. Clin Chim Acta. 1985, 151:285-91. 10.1016\/0009-8981(85)90091-9","journal-title":"Clin Chim Acta"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010143","article-title":"Laxative use in the community: a literature review","volume":"10","author":"Werth BL","year":"2021","unstructured":"Werth BL, Christopher SA. Laxative use in the community: a literature review. J Clin Med. 2021, 10:143. 10.3390\/jcm10010143","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5056\/jnm15187","article-title":"Prevalence and self-recognition of chronic constipation: results of an internet survey","volume":"22","author":"Tamura A","year":"2016","unstructured":"Tamura A, Tomita T, Oshima T, et al.. Prevalence and self-recognition of chronic constipation: results of an internet survey. J Neurogastroenterol Motil. 2016, 22:677-85. 10.5056\/jnm15187","journal-title":"J Neurogastroenterol Motil"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5056\/jnm20210","article-title":"Medical management of constipation in elderly patients: systematic review","volume":"27","author":"Kang SJ","year":"2021","unstructured":"Kang SJ, Cho YS, Lee TH, et al.. Medical management of constipation in elderly patients: systematic review. J Neurogastroenterol Motil. 2021, 27:495-512. 10.5056\/jnm20210","journal-title":"J Neurogastroenterol Motil"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.12.021","article-title":"Constipation and risk of death and cardiovascular events","volume":"281","author":"Sumida K","year":"2019","unstructured":"Sumida K, Molnar MZ, Potukuchi PK, et al.. Constipation and risk of death and cardiovascular events. Atherosclerosis. 2019, 281:114-20. 10.1016\/j.atherosclerosis.2018.12.021","journal-title":"Atherosclerosis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2020.08.005","article-title":"Laxative use and change in estimated glomerular filtration rate in patients with advanced chronic kidney disease","volume":"31","author":"Sumida K","year":"2021","unstructured":"Sumida K, Dashputre AA, Potukuchi PK, et al.. Laxative use and change in estimated glomerular filtration rate in patients with advanced chronic kidney disease. J Ren Nutr. 2021, 31:361-9. 10.1053\/j.jrn.2020.08.005","journal-title":"J Ren Nutr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.10.3473","article-title":"Constipation severity and quality of life among patients with cancer who received prophylactic laxatives: quasi-experimental study","volume":"23","author":"Ahmad M","year":"2022","unstructured":"Ahmad M, Alnaeem MM. Constipation severity and quality of life among patients with cancer who received prophylactic laxatives: quasi-experimental study. Asian Pac J Cancer Prev. 2022, 23:3473-80. 10.31557\/APJCP.2022.23.10.3473","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15020226","article-title":"Association between drug usage and constipation in the elderly population of Greater Western Sydney Australia","volume":"15","author":"Fragakis A","year":"2018","unstructured":"Fragakis A, Zhou J, Mannan H, Ho V. Association between drug usage and constipation in the elderly population of Greater Western Sydney Australia. Int J Environ Res Public Health. 2018, 15:226. 10.3390\/ijerph15020226","journal-title":"Int J Environ Res Public Health"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305390","article-title":"Diet pill and laxative use for weight control and subsequent incident eating disorder in US young women: 2001-2016","volume":"110","author":"Levinson JA","year":"2020","unstructured":"Levinson JA, Sarda V, Sonneville K, Calzo JP, Ambwani S, Austin SB. Diet pill and laxative use for weight control and subsequent incident eating disorder in US young women: 2001-2016. Am J Public Health. 2020, 110:109-11. 10.2105\/AJPH.2019.305390","journal-title":"Am J Public Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jand.2016.09.021","article-title":"Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber","volume":"117","author":"McRorie JW Jr","year":"2017","unstructured":"McRorie JW Jr, McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. J Acad Nutr Diet. 2017, 117:251-64. 10.1016\/j.jand.2016.09.021","journal-title":"J Acad Nutr Diet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028336","article-title":"Beneficial effects of Aloe ferox on lipid profile, blood pressure, and glycemic control in obese persons: a CONSORT-clinical study","volume":"100","author":"Gherbon A","year":"2021","unstructured":"Gherbon A, Frandes M, Timar R, Nicula M. Beneficial effects of Aloe ferox on lipid profile, blood pressure, and glycemic control in obese persons: a CONSORT-clinical study. Medicine (Baltimore). 2021, 100:e28336. 10.1097\/MD.0000000000028336","journal-title":"Medicine (Baltimore)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s11938-017-0151-1","article-title":"Diabetes mellitus and the colon","volume":"15","author":"Piper MS","year":"2017","unstructured":"Piper MS, Saad RJ. Diabetes mellitus and the colon. Curr Treat Options Gastroenterol. 2017, 15:460-74. 10.1007\/s11938-017-0151-1","journal-title":"Curr Treat Options Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2010.01611.x","article-title":"Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress","volume":"23","author":"Chandrasekharan B","year":"2011","unstructured":"Chandrasekharan B, Anitha M, Blatt R, et al.. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011, 23:131-8, e26. 10.1111\/j.1365-2982.2010.01611.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-016-0724-2","article-title":"Management of chronic constipation in patients with diabetes mellitus","volume":"36","author":"Prasad VG","year":"2017","unstructured":"Prasad VG, Abraham P. Management of chronic constipation in patients with diabetes mellitus. Indian J Gastroenterol. 2017, 36:11-22. 10.1007\/s12664-016-0724-2","journal-title":"Indian J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i6.893","article-title":"Blood glucose response after oral lactulose intake in type 2 diabetic individuals","volume":"12","author":"Pieber TR","year":"2021","unstructured":"Pieber TR, Svehlikova E, Mursic I, et al.. Blood glucose response after oral lactulose intake in type 2 diabetic individuals. World J Diabetes. 2021, 12:893-907. 10.4239\/wjd.v12.i6.893","journal-title":"World J Diabetes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1080\/10409230290771519","article-title":"Effects of consumption of probiotics and prebiotics on serum lipid levels in humans","volume":"37","author":"Pereira DI","year":"2002","unstructured":"Pereira DI, Gibson GR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol. 2002, 37:259-81. 10.1080\/10409230290771519","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/NT.0000000000000082","article-title":"Evidence-based approach to fiber supplements and clinically meaningful health benefits, Part 1: what to look for and how to recommend an effective fiber therapy","volume":"50","author":"McRorie JW Jr","year":"2015","unstructured":"McRorie JW Jr. Evidence-based approach to fiber supplements and clinically meaningful health benefits, Part 1: what to look for and how to recommend an effective fiber therapy. Nutr Today. 2015, 50:82-9. 10.1097\/NT.0000000000000082","journal-title":"Nutr Today"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-018-0713-9","article-title":"Phytochemical composition, antilipidemic and antihypercholestrolemic perspectives of bael leaf extracts","volume":"17","author":"Asghar N","year":"2018","unstructured":"Asghar N, Mushtaq Z, Arshad MU, Imran M, Ahmad RS, Hussain SM. Phytochemical composition, antilipidemic and antihypercholestrolemic perspectives of bael leaf extracts. Lipids Health Dis. 2018, 17:68. 10.1186\/s12944-018-0713-9","journal-title":"Lipids Health Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(18)30123-7","article-title":"Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial","volume":"3","author":"Nakajima A","year":"2018","unstructured":"Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol. 2018, 3:537-47. 10.1016\/s2468-1253(18)30123-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2018.1522248","article-title":"Elobixibat for the treatment of constipation","volume":"12","author":"Chedid V","year":"2018","unstructured":"Chedid V, Vijayvargiya P, Camilleri M. Elobixibat for the treatment of constipation. Expert Rev Gastroenterol Hepatol. 2018, 12:951-60. 10.1080\/17474124.2018.1522248","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X14528269","article-title":"Elobixibat and its potential role in chronic idiopathic constipation","volume":"7","author":"Acosta A","year":"2014","unstructured":"Acosta A, Camilleri M. Elobixibat and its potential role in chronic idiopathic constipation. Therap Adv Gastroenterol. 2014, 7:167-75. 10.1177\/1756283X14528269","journal-title":"Therap Adv Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.753938","article-title":"Promelaxin microenemas are non-inferior to oral polyethylene glycol for the treatment of functional constipation in young children: a randomized clinical trial","volume":"9","author":"Strisciuglio C","year":"2021","unstructured":"Strisciuglio C, Coppola V, Russo M, et al.. Promelaxin microenemas are non-inferior to oral polyethylene glycol for the treatment of functional constipation in young children: a randomized clinical trial. Front Pediatr. 2021, 9:753938. 10.3389\/fped.2021.753938","journal-title":"Front Pediatr"},{"key":"ref39","article-title":"Chronic constipation: current treatment options","volume":"25 Suppl B","author":"Liu LW","year":"2011","unstructured":"Liu LW. Chronic constipation: current treatment options. Can J Gastroenterol. 2011, 25 Suppl B:22B-8B.","journal-title":"Can J Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13467","article-title":"Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents","volume":"20","author":"Tric\u00f2 D","year":"2018","unstructured":"Tric\u00f2 D, Natali A, Mari A, Ferrannini E, Santoro N, Caprio S. Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents. Diabetes Obes Metab. 2018, 20:2905-10. 10.1111\/dom.13467","journal-title":"Diabetes Obes Metab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010631","article-title":"Chronic constipation: a review of literature","volume":"97","author":"Forootan M","year":"2018","unstructured":"Forootan M, Bagheri N, Darvishi M. Chronic constipation: a review of literature. Medicine (Baltimore). 2018, 97:e10631. 10.1097\/MD.0000000000010631","journal-title":"Medicine (Baltimore)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.031","article-title":"Chronic constipation","volume":"94","author":"Bharucha AE","year":"2019","unstructured":"Bharucha AE, Wald A. Chronic constipation. Mayo Clin Proc. 2019, 94:2340-57. 10.1016\/j.mayocp.2019.01.031","journal-title":"Mayo Clin Proc"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.2920","article-title":"Fiber-enriched botanicals: a therapeutic tool against certain metabolic ailments","volume":"10","author":"Khalid W","year":"2022","unstructured":"Khalid W, Arshad MS, Jabeen A, Muhammad Anjum F, Qaisrani TB, Suleria HA. Fiber-enriched botanicals: a therapeutic tool against certain metabolic ailments. Food Sci Nutr. 2022, 10:3203-18. 10.1002\/fsn3.2920","journal-title":"Food Sci Nutr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.700718","article-title":"Fecal microbiota transplantation modulates the gut flora favoring patients with functional constipation","volume":"12","author":"Zhang X","year":"2021","unstructured":"Zhang X, Li N, Chen Q, Qin H. Fecal microbiota transplantation modulates the gut flora favoring patients with functional constipation. Front Microbiol. 2021, 12:700718. 10.3389\/fmicb.2021.700718","journal-title":"Front Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.1619","article-title":"Laxative and antioxidant effects of ramie (Boehmeria nivea L.) leaf extract in experimental constipated rats","volume":"8","author":"Lee HJ","year":"2020","unstructured":"Lee HJ, Choi EJ, Park S, Lee JJ. Laxative and antioxidant effects of ramie (Boehmeria nivea L.) leaf extract in experimental constipated rats. Food Sci Nutr. 2020, 8:3389-401. 10.1002\/fsn3.1619","journal-title":"Food Sci Nutr"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.12.043","article-title":"Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses","volume":"239","author":"Derosa G","year":"2015","unstructured":"Derosa G, Romano D, D'Angelo A, Maffioli P. Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. Atherosclerosis. 2015, 239:87-92. 10.1016\/j.atherosclerosis.2014.12.043","journal-title":"Atherosclerosis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/182116-the-effect-of-chronic-laxative-use-on-lipid-profile-and-hba1c-a-hospital-based-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:07Z","timestamp":1707509167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/182116-the-effect-of-chronic-laxative-use-on-lipid-profile-and-hba1c-a-hospital-based-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.45055","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,11]]}}}